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Recent regulatory changes place greater emphasis on
ensuring that new medicinal products are appropriately
licensed for use in children. The EU Paediatric Regula-
tion stipulates that development in this group should
follow a prospectively agreed paediatric investigation
plan (PIP) outlining all of the studies to be conducted.
For any medicine, finding the right dose is crucial if its
benefits are to be properly evaluated. However, dose-
finding in children may be challenging due to the varia-
bility of drug pharmacokinetics across age-groups and
the limited sample sizes available. In such cases, uncer-
tainty about likely drug effects in children may be
reduced by extrapolating from existing data in relevant
populations.
This review focuses on current strategies adopted in
PIPs to support paediatric dose-recommendations. Data
were extracted from 73 PIP opinions recently adopted
by the Paediatric Committee of the European Medicines
Agency. These PIP opinions represented a total of 79
development programs and comprised a total of 97
dose-investigation studies. This presentation discusses
the key findings of this review. We highlight common
assumptions made in extrapolations and find that few
steps are often taken to validate needed assumptions.
Sample sizes used to support dose-investigations are
found to be highly variable across programs, with low
numbers recruited from the very youngest age-groups.
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